PureCycle Technologies (PCT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Consent is solicited from holders of 5,893,827 outstanding warrants to amend the Warrant Agreement, lowering the Redemption Trigger Price from $18.00 to $14.38 per share, effective June 17, 2026.
If approved, the expiration date of all warrants will be extended to March 17, 2027, or the date fixed for redemption, whichever is earlier.
The Board unanimously approved and recommends the amendment, citing increased likelihood for warrant holders to realize value and for the company to raise up to $67.8 million if warrants are exercised.
The amendment is intended to benefit both the company and shareholders by facilitating earlier redemption and potential capital for global expansion.
Voting matters and shareholder proposals
The proposal requires written consent from holders of a majority of outstanding warrants; failure to respond or abstain counts as a vote against.
No shareholder proposals or director nominations were received for the 2026 annual meeting.
Board of directors and corporate governance
The Board, led by CEO Dustin Olson, unanimously recommends consenting to the amendment and will effectuate the extension if approved.
Board actions and recommendations are clearly communicated to warrant holders.
Latest events from PureCycle Technologies
- Record production, new funding, and strong trials set stage for growth despite ongoing losses.PCT
Q3 20249 Jul 2026 - Operational and commercial milestones, funding, and strong demand drive growth outlook.PCT
Q4 20248 Jul 2026 - First $1.6M revenue, 90% uptime, BOPP breakthroughs, and $59M+ capital raised in Q1 2025.PCT
Q1 20258 Jul 2026 - Record production and revenue growth, with robust liquidity and strong commercial momentum.PCT
Q1 20267 May 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.PCT
Proxy filing27 Mar 2026 - Annual meeting covers director elections, auditor ratification, executive pay, global growth, and ESG milestones.PCT
Proxy filing27 Mar 2026 - Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference23 Mar 2026 - Proposal seeks to lower warrant trigger price and extend expiration, pending majority consent.PCT
Proxy Filing16 Mar 2026 - Record Q4 production and $2.7M revenue growth set the stage for global expansion in 2026.PCT
Q4 202527 Feb 2026